ACLU Takes Federal Government to Court Over Abortion Pill Restrictions

It’s arguing that a decade-old FDA rule places an “undue burden” on women.

Protestors rally outside of the Supreme Court on March 2, 2016 during oral arguments in the Whole Woman's Health v. Hellerstedt case.Douliery Olivier/Sipa via AP Images

Fight disinformation. Get a daily recap of the facts that matter. Sign up for the free Mother Jones newsletter.

On Tuesday, the American Civil Liberties Union sued the Food and Drug Administration over the agency’s restrictions on medication abortion. The lawsuit, filed in a U.S. District Court on behalf of a Hawaii doctor and several health care associations, specifically targets a restriction on mifepristone, a common drug used in medication abortion. 

Medication abortion involves two drugs, mifepristone and misoprostol. The FDA’s current rules, implemented in 2007, only allow mifepristone to be dispensed at a medical facility, like a doctor’s office or a clinic. By contrast, misoprostol is available at pharmacies with a prescription. Dr. Graham Chelius, a family medicine doctor in Hawaii and a plaintiff in the suit, says that the mifepristone restriction has made it nearly impossible for patients in rural Hawaii to access the procedure at all. That’s because, he says, some hospitals in the state, including his own, don’t stock mifepristone. 

“Because of the FDA’s restrictions,” said Chelius in a press release, “my patients are forced either to fly to a different provider on another island—resulting in serious delays—or to carry a pregnancy to term against their will.” According to the lawsuit, carrying a pregnancy to term poses a risk of fatality that is fourteen times greater than taking Mileprex, the brand name for mifepristone.

“The FDA restrictions harm patients by delaying time sensitive healthcare, imposing needless costs, and blocking some women from accessing abortion at all,” Julia Kaye, a staff attorney with the ACLU’s Reproductive Freedom Project, told reporters. 

More than a third of people who choose to end their pregnancies use medication abortion to do so, according to the Guttmacher Institute.

Chelius and the ACLU are hoping to overturn the FDA rule, which would then allow patients to pick up prescriptions for mifepristone at their local pharmacy and expand access to the procedure for low-income and rural women. 

“This case is about where a woman is standing when the pill is handed to her,” says Kaye. “This is about abortion stigma, not science.” 

HERE ARE THE FACTS:

Our fall fundraising drive is off to a rough start, and we very much need to raise $250,000 in the next couple of weeks. If you value the journalism you get from Mother Jones, please help us do it with a donation today.

As we wrote over the summer, traffic has been down at Mother Jones and a lot of sites with many people thinking news is less important now that Donald Trump is no longer president. But if you're reading this, you're not one of those people, and we're hoping we can rally support from folks like you who really get why our reporting matters right now. And that's how it's always worked: For 45 years now, a relatively small group of readers (compared to everyone we reach) who pitch in from time to time has allowed Mother Jones to do the type of journalism the moment demands and keep it free for everyone else.

Please pitch in with a donation during our fall fundraising drive if you can. We can't afford to come up short, and there's still a long way to go by November 5.

payment methods

ONE MORE QUICK THING:

Our fall fundraising drive is off to a rough start, and we very much need to raise $250,000 in the next couple of weeks. If you value the journalism you get from Mother Jones, please help us do it with a donation today.

As we wrote over the summer, traffic has been down at Mother Jones and a lot of sites with many people thinking news is less important now that Donald Trump is no longer president. But if you're reading this, you're not one of those people, and we're hoping we can rally support from folks like you who really get why our reporting matters right now. And that's how it's always worked: For 45 years now, a relatively small group of readers (compared to everyone we reach) who pitch in from time to time has allowed Mother Jones to do the type of journalism the moment demands and keep it free for everyone else.

Please pitch in with a donation during our fall fundraising drive if you can. We can't afford to come up short, and there's still a long way to go by November 5.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate